プロテインAレジン市場：製品（アガロースベース、ガラス/シリカベース、有機ポリマーベース）、タイプ（リコンビナントプロテインA、ナチュラルプロテインA）、アプリケーション（抗体精製、免疫沈降）、エンドユーザー＆地域別 - 2028年までの世界予測

Protein A Resin Market by Product (Agarose-based, Glass/Silica-based, Organic polymer-based), Type (Recombinant Protein A, Natural Protein A), Application (Antibody Purification, Immunoprecipitation), End User & Region - Global Forecast to 2028

プロテインA樹脂の世界市場は、2022年の12億米ドルから2028年には21億米ドルに達し、予測期間中にCAGR 9.8%で成長すると予測されます。治療薬に使用されるプロテインA樹脂の利点の増加は、予測される数年間の市場... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年4月5日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	145	113	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

プロテインA樹脂の世界市場は、2022年の12億米ドルから2028年には21億米ドルに達し、予測期間中にCAGR 9.8%で成長すると予測されます。治療薬に使用されるプロテインA樹脂の利点の増加は、予測される数年間の市場成長を後押しする主要な要因の1つであると予想されます。

"2022年、アガロースベースのプロテインA樹脂分野が市場最大シェアを占める"
アガロースは、タンパク質と結合するリガンドの付着に最も広く使用されているマトリックス樹脂であるため、2022年にはアガロースベースのプロテインA樹脂市場が最大のシェアを占めています。

"2022年、リコンビナントプロテインA樹脂分野が市場最大シェアを占める"
タイプ別では、プロテインA樹脂市場は、組み換えプロテインA樹脂と天然プロテインA樹脂に区分されます。2022年の市場シェアは組換えプロテインA分野が大きく、予測期間中はより高いCAGRを記録すると推定されます。このセグメントの高成長は、創薬や抗体精製のための技術進歩が進んでいることに起因すると考えられます。

"抗体精製分野は予測期間中に最も高いCAGRを記録すると予測される"
アプリケーションに基づき、プロテインA樹脂市場は抗体精製と免疫沈降に区分されます。抗体精製アプリケーションセグメントは2022年に市場を支配し、予測期間中に高いCAGRを記録することが予想されます。このセグメントの高い成長は、主に、抗体の下流処理における使用の増加、治療目的だけでなく研究目的でもmAbの需要が増加していることに起因していると考えられます。

"製薬・バイオ医薬品企業セグメントは、予測期間中に最も高いCAGRを記録すると予測される"
エンドユーザー市場は、製薬・バイオ医薬品企業、学術研究機関、その他のエンドユーザーに区分されます。2022年の世界のプロテインA樹脂市場では、製薬・バイオ製薬会社が最大のシェアを占めています。また、このエンドユーザー分野は、予測期間中に最も高いCAGRで成長すると推定されます。これは、腫瘍、結核、自己免疫疾患などの異なる疾患の治療領域でモノクローナル抗体の使用が増加していることなどの要因に起因しています。

"2022年、北米地域の市場がプロテインA樹脂の大きな市場シェアを占めると予想される。"
プロテインA樹脂市場は、北米、欧州、アジア太平洋、中南米、中東・アフリカの5つの主要地域をカバーしています。北米地域の市場は、2022年にプロテインA樹脂の重要な市場シェアを占めると予想されています。この地域におけるプロテインA樹脂市場の成長は、医薬品の研究開発への投資の増加や、研究開発活動への政府からの資金援助に起因していると思われます。

本レポートで参照した主な参加者の内訳は以下のとおりです：
- 企業タイプ別ティア1-48％、ティア2-36％、ティア3-16％：ティア1-48％、ティア2-36％、ティア3-16％。
- 役職別Cレベル-10％、ディレクターレベル-14％、その他-76
- 地域別北米40％、欧州32％、アジア太平洋20％、中南米5％、中近東・アフリカ3％。

プロテインA樹脂市場の著名なプレーヤーは、Danaher Corporation（米国）、Merck KGaA（ドイツ）、Repligen Corporation（米国）、Bio-Rad Laboratories, Inc（米国）、Thermo Fisher Scientific Inc（米国）、Tosoh Corporation（日本）などです。
調査対象
本レポートでは、プロテインA樹脂の市場を製品、タイプ、用途、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を網羅し、市場における様々な機会と課題を分析し、市場リーダーのための競争環境の詳細を提供します。さらに、ミクロ市場を個々の成長動向に関して分析し、主要5地域（およびこれらの地域のそれぞれの国）に関して、市場セグメントの収益を予測しています。
レポート購入の理由
本レポートは、C4ISR市場全体とサブセグメントの収益数の最も近い近似値に関する情報を提供し、本市場のマーケットリーダー/新規参入者の助けとなります。本レポートは、関係者が競争環境を理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、および機会に関する情報を提供します。
本レポートは、以下のポイントに関する洞察を提供します：

- 主要な推進要因（意思決定を支援する統合状況認識の強化ニーズ、非対称戦の脅威に対処するための防衛能力の近代化、無線接続と技術に対する軍事的関心の高まり）、阻害要因（C4システムの高い開発・保守コスト、サイバー攻撃への脆弱性。技術移転に関連する規制上の障害）、機会（軍事機器/技術間の相互運用性の必要性の高まり。C4ISR市場の成長に影響を与える課題（効果的な意思決定を支援するAIの利用拡大、C4ISR向けクラウドコンピューティングおよびデータストレージソリューション）、および課題（多様な脅威に対処する既存の電子戦システムの無力さ）。
- 製品開発/イノベーション：C4ISR市場における今後の技術、研究開発活動、新製品・新サービスの発売に関する詳細な考察
- 市場開拓：有利な市場に関する包括的な情報 - 当レポートでは、さまざまな地域のC4ISR市場を分析しています。
- 市場の多様化：C4ISR市場における新製品・サービス、未開拓地域、最新動向、投資に関する情報を網羅的に提供
- 競争力のある評価：C4ISR市場におけるLockheed Martin Corporation（米国）、Raytheon Technologies Corporation（米国）、Thales（フランス）、BAE Systems Inc（英国）、General Dynamics Corporation（米国）、Northrop Grumman（米国）などの主要企業の市場シェア、成長戦略、サービス提供などを詳細に評価します。
- 製品開発/イノベーション：プロテインA樹脂市場の今後の動向、研究開発活動、製品発表に関する詳細な洞察
- 市場開拓：有利な新興地域に関する包括的な情報
- 市場の多様化：プロテインA樹脂市場の新製品、成長地域、最新動向を網羅的に紹介
- 競合他社の評価：主要市場プレイヤーの市場セグメント、成長戦略、収益分析、製品に関する詳細な評価。

ページTOPに戻る

1 INTRODUCTION 18
1.1 STUDY OBJECTIVES 18
1.2 MARKET DEFINITION 18
1.3 INCLUSIONS AND EXCLUSIONS 19
TABLE 1 PROTEIN A RESIN MARKET: INCLUSIONS AND EXCLUSIONS 19
1.4 MARKETS COVERED 19
FIGURE 1 MARKET SEGMENTATION 19
1.4.1 GEOGRAPHIC SEGMENTATION 20
1.5 YEARS CONSIDERED 20
1.6 CURRENCY CONSIDERED 20
1.7 LIMITATIONS 21
1.8 STAKEHOLDERS 21
1.9 SUMMARY OF CHANGES 21
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH DATA 23
2.2 RECESSION IMPACT 23
FIGURE 2 RESEARCH DESIGN 24
2.2.1 SECONDARY RESEARCH 25
2.2.2 PRIMARY RESEARCH 26
2.2.2.1 Primary sources 26
2.2.2.2 Key industry insights 27
2.2.2.3 Breakdown of primaries 27
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 27
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28
2.3 RESEARCH ASSUMPTION 28
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 29
2.3.1 BOTTOM-UP APPROACH 29
2.3.1.1 Approach 1: Company revenue estimation approach 30
FIGURE 6 MARKET SIZE ESTIMATION: VENDOR REVENUE MAPPING APPROACH 30
FIGURE 7 ANALYSIS OF VENDOR REVENUE MAPPING 31
2.3.1.2 Approach 2: Customer-based market estimation 31
FIGURE 8 PROTEIN A RESIN MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 32
2.3.1.3 CAGR projection 32
FIGURE 9 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 32
2.4 DATA VALIDATION APPROACH 33
FIGURE 10 DATA TRIANGULATION METHODOLOGY 33
2.5 MARKET SHARE ASSESSMENT 34
2.6 STUDY ASSUMPTIONS 34
2.7 RISK ASSESSMENT 34
2.7.1 PROTEIN A RESIN MARKET: RISK ASSESSMENT 34
2.8 GROWTH RATE ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
FIGURE 11 PROTEIN A RESIN MARKET, BY PRODUCT, 2022 VS. 2028 (USD MILLION) 36
FIGURE 12 PROTEIN A RESIN MARKET, BY TYPE, 2022 VS. 2028 (USD MILLION) 37
FIGURE 13 PROTEIN A RESIN MARKET, BY APPLICATION, 2022 VS. 2028 (USD MILLION) 37
FIGURE 14 PROTEIN A RESIN MARKET, BY END USER, 2022 VS. 2028 (USD MILLION) 38
FIGURE 15 GEOGRAPHIC SNAPSHOT: PROTEIN A RESIN MARKET 39
4 PREMIUM INSIGHTS 40
4.1 PROTEIN A RESIN MARKET OVERVIEW 40
FIGURE 16 INCREASING DEMAND FOR PRE-PACKED DISPOSABLE COLUMNS TO DRIVE MARKET GROWTH 40
4.2 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2022 VS. 2028 (USD MILLION) 41
FIGURE 17 AGAROSE-BASED PROTEIN A SEGMENT TO DOMINATE NORTH AMERICAN MARKET DURING FORECAST PERIOD 41
4.3 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2022 VS. 2028 (USD MILLION) 41
FIGURE 18 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES SEGMENT TO CONTINUE TO DOMINATE ASIA PACIFIC MARKET DURING FORECAST PERIOD 41
4.4 GEOGRAPHIC SNAPSHOT OF PROTEIN A RESIN MARKET 42
FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
FIGURE 20 PROTEIN A RESIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43
5.2.1 DRIVERS 44
5.2.1.1 Growing demand for disposable pre-packed columns 44
TABLE 2 ADVANTAGES OF PRE-PACKED COLUMNS 44
5.2.1.2 Increasing demand for therapeutic antibodies 44
5.2.1.3 Increasing pharmaceutical R&D spending 45
5.2.1.4 Stringent regulatory control in healthcare industry 45
5.2.2 RESTRAINTS 45
5.2.2.1 High cost of resins 45
5.2.2.2 Dearth of skilled professionals 45
5.2.3 OPPORTUNITIES 46
5.2.3.1 Increasing number of CMOs and CROs 46
5.2.4 CHALLENGES 46
5.2.4.1 Regulatory restrictions 46
5.2.4.2 Issues associated with scaling up production of protein A resins 47
5.3 REGULATIONS 47
5.3.1 NORTH AMERICA 47
5.3.1.1 US 47
5.3.1.2 Canada 47
5.3.2 EUROPE 48
5.3.3 ASIA PACIFIC 48
5.3.4 LATIN AMERICA 49
5.3.5 MIDDLE EAST & AFRICA 49
5.4 PRICING ANALYSIS: PROTEIN A RESIN MARKET 49
5.5 PORTER’S FIVE FORCES ANALYSIS 50
TABLE 3 PROTEIN A RESIN MARKET: PORTER’S FIVE FORCES ANALYSIS 50
5.5.1 THREAT OF SUBSTITUTES 50
5.5.2 BARGAINING POWER OF SUPPLIERS 51
5.5.3 BARGAINING POWER OF BUYERS 51
5.5.4 THREAT OF NEW ENTRANTS 52
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 52
6 PROTEIN A RESIN MARKET, BY PRODUCT 53
6.1 INTRODUCTION 54
TABLE 4 PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 54
6.2 AGAROSE-BASED PROTEIN A 54
6.2.1 AGAROSE-BASED PROTEIN A SEGMENT TO DOMINATE MARKET 54
TABLE 5 AGAROSE-BASED PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 55
TABLE 6 NORTH AMERICA: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 55
TABLE 7 EUROPE: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 55
TABLE 8 ASIA PACIFIC: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 56
6.3 GLASS/SILICA-BASED PROTEIN A 56
6.3.1 LOW PH TOLERANCE OF SILICA-BASED RESINS TO LIMIT THEIR MARKET GROWTH 56
TABLE 9 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 56
TABLE 10 NORTH AMERICA: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 57
TABLE 11 EUROPE: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 57
TABLE 12 ASIA PACIFIC: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 58

6.4 ORGANIC POLYMER-BASED PROTEIN A 58
6.4.1 INCREASING POPULARITY OF ORGANIC POLYMERS TO DRIVE MARKET GROWTH 58
TABLE 13 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 59
TABLE 14 NORTH AMERICA: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 59
TABLE 15 EUROPE: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 59
TABLE 16 ASIA PACIFIC: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 60
7 PROTEIN A RESIN MARKET, BY TYPE 61
7.1 INTRODUCTION 62
TABLE 17 PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 62
7.2 RECOMBINANT PROTEIN A 62
7.2.1 COST-EFFICIENCY OF RECOMBINANT PROTEINS TO DRIVE MARKET GROWTH 62
TABLE 18 RECOMBINANT PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 63
7.3 NATURAL PROTEIN A 63
7.3.1 ADVANTAGES OF RECOMBINANT PROTEIN A HAVE RESTRICTED MARKET POTENTIAL OF NATURAL PROTEIN A 63
TABLE 19 NATURAL PROTEIN A MARKET, BY REGION, 2020–2028 (USD MILLION) 63
8 PROTEIN A RESIN MARKET, BY APPLICATION 64
8.1 INTRODUCTION 65
TABLE 20 PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 65
8.2 ANTIBODY PURIFICATION 65
8.2.1 ANTIBODY PURIFICATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 65
TABLE 21 PROTEIN A RESIN MARKET FOR ANTIBODY PURIFICATION, BY REGION, 2020–2028 (USD MILLION) 66
8.3 IMMUNOPRECIPITATION 66
8.3.1 IMMUNOPRECIPITATION SEGMENT TO GROW AT LOWER CAGR DURING FORECAST PERIOD 66
TABLE 22 PROTEIN A RESIN MARKET FOR IMMUNOPRECIPITATION, BY REGION, 2020–2028 (USD MILLION) 66
9 PROTEIN A RESIN MARKET, BY END USER 67
9.1 INTRODUCTION 68
TABLE 23 PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 68
9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 68
9.2.1 PROTEIN A RESINS EXTENSIVELY USED TO PRODUCE BIOLOGICAL DRUGS 68
FIGURE 21 SPENDING ON PHARMACEUTICAL RESEARCH AND DEVELOPMENT, 2020–2028 (USD BILLION) 69
TABLE 24 PROTEIN A RESIN MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2028 (USD MILLION) 69
9.3 ACADEMIC RESEARCH INSTITUTES 70
9.3.1 INCREASING R&D IN DRUG DISCOVERY TO DRIVE USE OF PROTEIN A RESINS 70
TABLE 25 PROTEIN A RESIN MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2028 (USD MILLION) 70
9.4 OTHER END USERS 70
TABLE 26 PROTEIN A RESIN MARKET FOR OTHER END USERS, BY REGION, 2020–2028 (USD MILLION) 71
10 PROTEIN A RESIN MARKET, BY REGION 72
10.1 INTRODUCTION 73
TABLE 27 PROTEIN A RESIN MARKET, BY REGION, 2020–2028 (USD MILLION) 73
10.2 NORTH AMERICA 74
FIGURE 22 NORTH AMERICA: PROTEIN A RESIN MARKET SNAPSHOT 74
TABLE 28 NORTH AMERICA: PROTEIN A RESIN MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 75
TABLE 29 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 75
TABLE 30 NORTH AMERICA: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 75
TABLE 31 NORTH AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 76
TABLE 32 NORTH AMERICA: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 76
10.2.1 US 76
10.2.1.1 Increasing R&D investments in pharmaceutical industry to propel market growth 76
TABLE 33 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 77
10.2.2 CANADA 77
10.2.2.1 Government initiatives focused on boosting pharmaceutical industry to drive market growth 77
TABLE 34 CANADA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 77
10.3 EUROPE 78
TABLE 35 EUROPE: PROTEIN A RESIN MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 78
TABLE 36 EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 78
TABLE 37 EUROPE: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 79
TABLE 38 EUROPE: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 79
TABLE 39 EUROPE: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 79
10.3.1 GERMANY 80
10.3.1.1 Flourishing biotechnology industry to drive market growth 80
TABLE 40 GERMANY: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 80

10.3.2 UK 80
10.3.2.1 Favorable R&D scenario to support market growth 80
TABLE 41 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 81
10.3.3 FRANCE 81
10.3.3.1 Favorable healthcare scenario to boost market growth 81
TABLE 42 FRANCE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 81
10.3.4 ITALY 82
10.3.4.1 Well-established pharmaceutical industry to spur demand for protein A resins 82
TABLE 43 ITALY: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 82
10.3.5 SPAIN 82
10.3.5.1 Presence of large number of biotech R&D service providers to support market growth 82
TABLE 44 SPAIN: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 83
10.3.6 REST OF EUROPE 83
TABLE 45 REST OF EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 84
10.4 ASIA PACIFIC 85
FIGURE 23 ASIA PACIFIC: PROTEIN A RESIN MARKET SNAPSHOT 85
TABLE 46 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 86
TABLE 47 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 86
TABLE 48 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 86
TABLE 49 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 87
TABLE 50 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 87
10.4.1 JAPAN 87
10.4.1.1 Increasing demand for generic drugs and monoclonal antibody biosimilars to drive resin consumption 87
TABLE 51 JAPAN: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 88
10.4.2 CHINA 88
10.4.2.1 Increasing pharmaceutical R&D spending to drive market growth 88
TABLE 52 CHINA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 88
10.4.3 INDIA 89
10.4.3.1 Growth of pharma and biotech industries to drive demand for protein A resins 89
TABLE 53 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 89

10.4.4 AUSTRALIA 89
10.4.4.1 Increasing demand for protein-based therapeutics for treatment of infectious diseases to drive growth 89
TABLE 54 AUSTRALIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 90
10.4.5 SOUTH KOREA 90
10.4.5.1 Developments in biopharmaceutical sector to drive market growth 90
TABLE 55 SOUTH KOREA: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 90
10.4.6 REST OF ASIA PACIFIC 91
TABLE 56 REST OF ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 91
10.5 REST OF THE WORLD 91
TABLE 57 ROW: PROTEIN A RESIN MARKET, BY PRODUCT, 2020–2028 (USD MILLION) 92
TABLE 58 ROW: PROTEIN A RESIN MARKET, BY TYPE, 2020–2028 (USD MILLION) 92
TABLE 59 ROW: PROTEIN A RESIN MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 92
TABLE 60 ROW: PROTEIN A RESIN MARKET, BY END USER, 2020–2028 (USD MILLION) 93
11 COMPETITIVE LANDSCAPE 94
11.1 OVERVIEW 94
11.2 MARKET SHARE ANALYSIS 94
FIGURE 24 PROTEIN A RESIN MARKET SHARE ANALYSIS (2021) 94
11.3 COMPETITIVE LEADERSHIP MAPPING 95
11.3.1 STARS 95
11.3.2 EMERGING LEADERS 95
11.3.3 PERVASIVE PLAYERS 95
11.3.4 PARTICIPANTS 95
FIGURE 25 PROTEIN A RESIN MARKET: COMPETITIVE LEADERSHIP MAPPING (2022) 96
11.4 COMPETITIVE SCENARIO 97
11.4.1 PRODUCT LAUNCHES 97
TABLE 61 PROTEIN A RESIN MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO FEBRUARY 2023 97
11.4.2 DEALS 97
TABLE 62 PROTEIN A RESIN MARKET: DEALS, JANUARY 2020 TO FEBRUARY 2023 97
11.4.3 OTHER DEVELOPMENTS 98
TABLE 63 PROTEIN A RESIN MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO FEBRUARY 2023 98

12 COMPANY PROFILES 99
12.1 KEY PLAYERS 99
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 DANAHER CORPORATION 99
TABLE 64 DANAHER CORPORATION: COMPANY OVERVIEW 99
FIGURE 26 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 100
12.1.2 THERMO FISHER SCIENTIFIC 103
TABLE 65 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW 103
FIGURE 27 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) 104
12.1.3 MERCK KGAA 107
TABLE 66 MERCK KGAA: COMPANY OVERVIEW 107
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2022) 108
12.1.4 REPLIGEN CORPORATION 110
TABLE 67 REPLIGEN CORPORATION: COMPANY OVERVIEW 110
FIGURE 29 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2022) 110
12.1.5 TOSOH BIOSCIENCE LLC 113
TABLE 68 TOSOH BIOSCIENCE LLC: COMPANY OVERVIEW 113
FIGURE 30 TOSOH BIOSCIENCE LLC: COMPANY SNAPSHOT (2021) 114
12.1.6 AGILENT TECHNOLOGIES, INC. 116
TABLE 69 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 116
FIGURE 31 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2022) 117
12.1.7 PUROLITE 120
TABLE 70 PUROLITE: COMPANY OVERVIEW 120
12.1.8 PERKINELMER INC. 122
TABLE 71 PERKINELMER INC.: COMPANY OVERVIEW 122
FIGURE 32 PERKINELMER INC.: COMPANY SNAPSHOT (2022) 123
12.1.9 NOVASEP HOLDING SAS 124
TABLE 72 NOVASEP HOLDING SAS: COMPANY OVERVIEW 124
12.1.10 GENSCRIPT 125
TABLE 73 GENSCRIPT: COMPANY OVERVIEW 125
FIGURE 33 GENSCRIPT: COMPANY SNAPSHOT (2021) 126
12.1.11 BIO-RAD LABORATORIES, INC. 127
TABLE 74 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 127
FIGURE 34 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 128
12.1.12 KANEKA CORPORATION 130
TABLE 75 KANEKA CORPORATION: COMPANY OVERVIEW 130
FIGURE 35 KANEKA CORPORATION: COMPANY SNAPSHOT (2021) 130
12.1.13 OROCHEM TECHNOLOGIES INC. 132
TABLE 76 OROCHEM TECHNOLOGIES INC.: COMPANY OVERVIEW 132

12.1.14 ABCAM PLC 133
TABLE 77 ABCAM PLC.: COMPANY OVERVIEW 133
12.1.15 AGAROSE BEAD TECHNOLOGIES 134
TABLE 78 AGAROSE BEAD TECHNOLOGIES: COMPANY OVERVIEW 134
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER COMPANIES 135
12.2.1 AVANTOR, INC. 135
12.2.2 JSR LIFESCIENCES, LLC 135
12.2.3 BIO-WORKS 136
12.2.4 TAKARA BIO INC. 136
12.2.5 GENERON 137
12.2.6 GENO TECHNOLOGY INC. 137
12.2.7 JNC CORPORATION 138
12.2.8 PROMEGA CORPORATION 138
12.2.9 SUZHOU NANOMICRO TECHNOLOGY CO., LTD. 139
12.2.10 TRANSGEN BIOTECH CO., LTD. 139
13 APPENDIX 140
13.1 DISCUSSION GUIDE 140
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 143
13.3 CUSTOMIZATION OPTIONS 145
13.4 RELATED REPORTS 145
13.5 AUTHOR DETAILS 147

ページTOPに戻る

Table of Contents

Summary

The global protein A resin market is projected to reach USD 2.1 billion by 2028 from USD 1.2 billion in 2022, growing at a CAGR of 9.8% during the forecast period. The rise in advantages offered by protein A resin to be used in therapeutics is one of the major factors anticipated to boost market growth in the forecasting years.

“The agarose-based protein A resin segment to hold the largest share of the market in 2022”
On the basis of product, the protein A resin market is segmented into agarose-based protein A, glass/silica-based protein A, and organic polymer-based protein A. The agarose-based protein A segment commanded the largest share of the market in 2022, as agarose is the most widely used matrix resin for the attachment of ligands that bind proteins.

“The recombinant protein A resin segment to hold the largest share of the market in 2022”
On the basis of type, the protein A resin market is segmented into recombinant and natural protein A resin. The recombinant protein A segment accounted for a larger market share in 2022 and is estimated to register a higher CAGR during the forecast period. The high growth of this segment can be attributed to the increasing technological advancements for the discovery of drugs and antibody purifications.

“The antibody purification segment is projected to register the highest CAGR during the forecast period”
Based on application, the protein A resin market is segmented into antibody purification and immunoprecipitation. The antibody purification application segment dominated the market in 2022 and is expected to register a higher CAGR during the forecast period. The high growth of this segment can primarily be attributed to the increasing use in downstream processing of the antibodies and increasing demand for mAbs for therapeutic as well as research purposes.

“The pharmaceutical & biopharmaceutical companies segment is projected to register the highest CAGR during the forecast period”
The end-user market is segmented into pharmaceutical and biopharmaceutical companies, academic research institutes, and other end users. Pharmaceutical and biopharmaceutical companies accounted for the largest share of the global protein A resin market in 2022. This end-user segment is also estimated to grow at the highest CAGR during the forecast period. This can be attributed to the factors such as increasing use for monoclonal antibodies in the therapeutic areas of different diseases like oncology, tuberculosis, and autoimmune diseases.

“The market in the North America region is expected to hold significant market share for protein A resin in 2022.”
The protein A resin market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market in the North America region is expected to hold significant market share for protein A resin in 2022. The growth of the protein A resin market in this region can be attributed to the increasing investments in pharmaceutical R&D and government funding for R&D activities.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%

The prominent players in the protein A resin market are Danaher Corporation (US), Merck KGaA (Germany), Repligen Corporation (US), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), and Tosoh Corporation (Japan) among others.
Research Coverage
This report studies the protein A resin market based on product, type, application, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall C4ISR market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:

• Analysis of key drivers (Need for enhanced integrated situational awareness to support decision making, modernization of defense capabilities to address asymmetric warfare threats, Rising Military focus on wireless connectivity and technologies), restraints (High Development and Maintenance costs of C4 System, Vulnerability to cyberattacks. Regulatory obstacles related to technology transfer), opportunities (Increasing need for interoperability between military devices/technologies. Incraesing use of AI to assist in effective decision making, Cloud computing and data storage solutions for C4ISR), and challenges (Inability of existing electronic warfare systems to address diverse threats) influencing the growth of the C4ISR market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the C4ISR market
• Market Development: Comprehensive information about lucrative markets – the report analyses the C4ISR market across varied regions
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the C4ISR market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Lockheed Martin Corporation (US), Raytheon Technologies Corporation (US), Thales (France), BAE Systems Inc. (UK), General Dynamics Corporation (US), and Northrop Grumman (US), among others in the C4ISR market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the protein A resin market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the protein A resin market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（抗生物薬）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（protein）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（抗生物薬）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（protein）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?